Hydronidone, formerly known as F-351, are Non-Steroidal Antiinflammatory Drugs (NSAIDs) potentially for the treatment of hepatic fibrosis. References: Liu Y, Wu J, Li Z, Luo Y, Zeng F, Shi S. Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study. Eur J Drug Metab Pharmacokinet. 2017 Feb;42(1):37-48. doi: 10.1007/s13318-015-0316-z. PubMed PMID: 26797810.

纯度：≥98%

CAS：851518-71-3